Financial Gravity Asset Management, Inc. Novo Nordisk A S Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

A detailed history of Financial Gravity Asset Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 23,382 shares of NVO stock, worth $2.46 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

23,382

Previous 23,509 0.54%

Holding current value

$2.46 Million

Previous $2.43 Billion 37.14%

% of portfolio

0.83%

Previous 0.68%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$122.71 - $146.91 $15,584 - $18,657	-127 Reduced 0.54%	23,382 $3.34 Billion
Q1 2024 Jun 26, 2024	SELL	$102.11 - $135.92 $204 - $271	-2 Reduced 0.01%	23,509 $2.43 Billion
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $23.7 Million - $31.5 Million	-231,819 Reduced 90.91%	23,177 $2.98 Billion
Q4 2023 Jun 26, 2024	BUY	$87.78 - $105.45 $29,318 - $35,220	334 Added 1.44%	23,511 $2.43 Billion
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $22.4 Million - $49.2 Million	246,334 Added 2843.85%	254,996 $23.2 Million
Q2 2023 Aug 08, 2023	SELL	$155.98 - $172.65 $40,710 - $45,061	-261 Reduced 2.93%	8,662 $2.2 Million
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $794,437 - $955,317	6,003 Added 205.58%	8,923 $5.75 Million
Q4 2022 Feb 15, 2023	SELL	$102.55 - $135.33 $39,379 - $51,966	-384 Reduced 11.62%	2,920 $1.32 Million
Q3 2022 Nov 03, 2022	SELL	$95.28 - $116.93 $550,242 - $675,270	-5,775 Reduced 63.61%	3,304 $285,000
Q2 2022 Aug 05, 2022	BUY	$103.24 - $121.81 $560,283 - $661,062	5,427 Added 148.6%	9,079 $935,000
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $382,082 - $461,864	-4,104 Reduced 52.91%	3,652 $339,000
Q4 2021 Feb 11, 2022	BUY	$95.88 - $117.08 $102,591 - $125,275	1,070 Added 16.0%	7,756 $680,000
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $707,101 - $893,049	-8,376 Reduced 55.61%	6,686 $731,000
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $95,874 - $120,104	1,417 Added 10.38%	15,062 $1.35 Million
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $403,231 - $455,905	6,013 Added 78.79%	13,645 $935,000
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $487,608 - $563,241	7,632 New	7,632 $533,000
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $116,260 - $134,928	-1,986 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$49.46 - $64.78 $93,083 - $121,915	1,882 Added 1809.62%	1,986 $119,000
Q4 2019 Feb 28, 2020	BUY	$49.86 - $58.26 $797 - $932	16 Added 18.18%	104 $58,000
Q3 2019 Oct 15, 2019	SELL	$47.54 - $53.43 $1,140 - $1,282	-24 Reduced 21.43%	88 $5,000
Q2 2019 Jul 26, 2019	SELL	$46.79 - $52.47 $3,977 - $4,459	-85 Reduced 43.15%	112 $6,000
Q1 2019 Apr 19, 2019	BUY	$46.36 - $52.63 $4,311 - $4,894	93 Added 89.42%	197 $10,000
Q3 2018 Oct 31, 2018	SELL	$46.76 - $51.24 $327 - $358	-7 Reduced 6.31%	104 $4,000
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $354 - $403	-8 Reduced 6.72%	111 $5,000
Q1 2018 May 23, 2018	BUY	$48.49 - $58.14 $5,770 - $6,918	119 New	119 $6,000

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account

Financial Gravity Asset Management, Inc. Novo Nordisk A S Transaction History